Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
D.F. Manfrin
Observed name:
DF Manfrin
Institution:
Amgen (United States)
Observed institutions:
Amgen (United States),
Pfizer (United States)
OpenAlex ID:
A5014029660
PSY46 Burden of Disease in Patients With Diagnosed Psoriasis in Brazil: Results From 2011 National Health and Wellness Survey (NHWS)
2012
·
R.K. Fujii
, J.F. Mould
, et al.
·
Value in Health
·
25
PDF
PSY36 Economic Evaluation of Pegvisomant for Active Acromegaly Patients who Failed Available Therapies in Brazil – Public Health Care System Perspective
2012
·
R.K. Fujii
, J.F. Mould
, et al.
·
Value in Health
·
4
PDF
Economic Burden of Hospitalized Pneumonia from a Private Health Care System Perspective in Brazil
2014
·
D.F. Manfrin
, C.N. Ferreira
, et al.
·
Value in Health
·
2
PIN66 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in São Paulo State, Brazil – Public Perspective
2012
·
R.K. Fujii
, C.S. Roberts
, et al.
·
Value in Health
·
2
PMH59 Burden of Disease in Patients with Diagnosed Depression in Brazil: Results from 2011 National Health and Wellness Survey (NHWS)
2012
·
J.F. Mould
, R.K. Fujii
, et al.
·
Value in Health
·
2
Budget Impact Analysis of 13-Valent Pneumococcal Vaccine in Adult Population with Comorbidities or Immunocompromised from the Public Payer Perspective In Brazil
2014
·
C.N. Ferreira
, D.F. Manfrin
, et al.
·
Value in Health
·
1
Economic Burden Of Psoriatic Patients In The Brazilian Health System
2014
·
CN Ferreira
, MD DiBonaventura
, et al.
·
Value in Health
·
1
Financial Analysis Of A Vaccination Campaign Using 13 Valent Pneumococcal Conjugated Vaccine (PCV13) With Employers
2014
·
C.N. Ferreira
, D.F. Manfrin
, et al.
·
Value in Health
·
1
PDF
Budget Impact Evaluation Of A Vaccination With Campaign Program For Corporations Using Pneumococcal Conjugated Vaccine (Pcv) 13 Valent Versus Pneumococcal Polisaccharide Vaccine (Ppv) 23 With Paid Campaign For Older Adults
2013
·
R.K. Fujii
, J. Presa
, et al.
·
Value in Health
·
1
Cost-Effectiveness Evaluation Of Amphotericin B, Amphotericin B Liposomal, Caspofungin And Voriconazol In Treating Aspergillosis Under The Brazilian Public Health Care System Perspective
2013
·
R.K. Fujii
, D.F. Manfrin
, et al.
·
Value in Health
·
1
Budget Impact Evaluation Of A Pneumococcal Conjugated Vaccine (Pcv) 13 Valent Vaccination With Free Campaign Program For Corporations Vesus No Vaccination For Older Adults
2013
·
R.K. Fujii
, J. Presa
, et al.
·
Value in Health
·
1
PSS11 Economic Analysis of Etanercept as Paused Therapy in Moderate to Severe Psoriasis from a Private Perspective in Brazil
2012
·
R.A. Fernandes
, M.L.S. Takemoto
, et al.
·
Value in Health
·
1
PND16 Economic Evaluation of Pregabalin and Gabapentin for Neuropathic Pain from the Brazilian Public Health Care System Perspective
2012
·
J.F. Mould
, R.K. Fujii
, et al.
·
Value in Health
·
1
An Observational Retrospective Cohort Database Study To Estimate Costs Regarding Immunoglobulin Use for Itp Treatment In The Brazilian Public Healthcare System
2017
·
AC Figueiredo
, RF dos Santos
, et al.
·
Value in Health
An Observational Cross-Sectional Database Study To Estimate Hospitalization Costs Related To Cardiovascular Disease In Brazilian Private Healthcare System
2017
·
RF dos Santos
, FP Alves
, et al.
·
Value in Health
Costs Related to Pneumonia, Meningitis and Sepsis in Patients 50 Years and Older from the Private Health System Perspective in Brazil
2014
·
D.F. Manfrin
, C.N. Ferreira
, et al.
·
Value in Health
Costs of Pneumonia in Patients With Cancer Diagnosis from the Private Health System Perspective in Brazil
2014
·
D.F. Manfrin
, C.N. Ferreira
, et al.
·
Value in Health
Cost Effectiveness Analysis Of Varenicline Use For Smoking Cessation In The City Of São Paulo From The Public Health System Perspective
2014
·
L.D. Portela
, J.S. Issa
, et al.
·
Value in Health
Comparative cost analysis for treating growth hormone deficience in Brazil: Pen versus syringes
2014
·
M.A. Silva
, I.M. Mello
, et al.
·
Value in Health
Cost Analysis of Adverse Events Associated with First Line Treatment for Metastatic Renal Cell Carcinoma (MRCC) in the Perspective of Public and Private Health Insurance in Brazil
2014
·
C.N. Ferreira
, C.S. Rufino
, et al.
·
Value in Health
Economic Burden Associated To Tobacco In The Brazilian Population
2014
·
C.N. Ferreira
, C.S. Rufino
, et al.
·
Value in Health
PDF
Somatropin dose analysis for treatment of hypopituitarism in public Brazilian health system (SUS)
2014
·
C.N. Ferreira
, C.S. Rufino
, et al.
·
Value in Health
Economic Impact of Stroke Episode in Patients Previous Diagnosed with Atrial Fibrillation in Private Health System in Brazil
2013
·
G. Araújo
, A.M. Santos
, et al.
·
Value in Health
Adherence to Warfarin Treatment in Brazil: Systematic Review of the Literature
2013
·
L.F. Feijo
, O.A.C. Clark
, et al.
·
Value in Health
PDF
Parecoxib versus ketoprophene, ketorolac, and tenoxicam in acute post-surgical pain management: a cost-minimization analysis from the private hospital perspective in Brazil
2013
·
J.F. Vasconcellos
, P.M.L. Santos
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
35
Citation count:
43
H-index:
2
I10-index:
1
Year
Topic
Type
